
Who will acquire 23andMe?
Plus
54
Ṁ6431Dec 31
88%
Anne Wojcicki
22%
Regeneron
12%
Hypera Pharma
11%
Roche
9%
Merck
9%
Johnson & Johnson
9%
Novartis
6%
Pfizer
5%
Eli Lilly
5%
Elon Musk
Update 2025-07-03 (PST) (AI summary of creator comment): In the event that 23andMe's assets are acquired by TTAM Research Institute, the market will resolve to Anne Wojcicki.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
Sort by:
On June 27, 2025, the U.S. Bankruptcy Court for the Eastern District of Missouri approved the proposed purchase of all of the assets of 23andMe by TTAM Research Institute (“TTAM”), and we anticipate that the sale will close on or as soon as reasonably practicable after July 8, 2025.
TTAM is a nonprofit medical research organization founded by Anne Wojcicki (Co-Founder and former CEO of 23andMe).
@PaintspotInfez No, because they are not mutually exclusive. A deal where eg Eli Lily and Pfizer cooperate to keep 23&me alive is possible
Related questions
Related questions
Will 23andMe be bought before the end of 2025?
75% chance
What will 23andMe’s status be on Dec 31, 2025?
Will common shareholders recover any value from 23andMe's bankruptcy?
65% chance
Will Illumina be subject to M&A before end of 2025
38% chance
By which year will most Americans have had their DNA sequenced?